Inhibition of HER2 tyrosine kinase disrupts androgen-receptor functioning

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2005年 / 2卷 / 6期
关键词：
D O I：
10.1038/ncpuro0192
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：264 / 265
页数：1
相关论文
共 50 条
  • [21] The role of oestrogen receptor α in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2
    Kavanagh, Dara O.
    McIlroy, Marie
    Myers, Eddie
    Bane, Fiona
    Crotty, Thomas B.
    McDermott, E.
    Hill, Arnold D.
    Young, Leonie S.
    ENDOCRINE-RELATED CANCER, 2010, 17 (01) : 255 - 264
  • [22] Lapatinib: A novel EGFR/HER2 tyrosine kinase inhibitor for cancer
    Johnston, Stephen R. D.
    Leary, Alex
    DRUGS OF TODAY, 2006, 42 (07) : 441 - 453
  • [23] Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity
    Montemurro, Filippo
    Valabrega, Giorgio
    Aglietta, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) : 257 - 268
  • [24] Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors
    Chandrika, Bhavya Balan
    Steephan, Mathew
    Kumar, T. R. Santhosh
    Sabu, A.
    Haridas, M.
    LIFE SCIENCES, 2016, 160 : 47 - 56
  • [25] Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
    He, Licai
    Du, Zhuanyun
    Xiong, Xusheng
    Ma, Hua
    Zhu, Zhenfeng
    Gao, Hongwei
    Cao, Jiawei
    Li, Tong
    Li, Hongzhi
    Yang, Kaiyan
    Chen, Guorong
    Richer, Jennifer K.
    Gu, Haihua
    SCIENTIFIC REPORTS, 2017, 7
  • [26] Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
    Licai He
    Zhuanyun Du
    Xusheng Xiong
    Hua Ma
    Zhenfeng Zhu
    Hongwei Gao
    Jiawei Cao
    Tong Li
    Hongzhi Li
    Kaiyan Yang
    Guorong Chen
    Jennifer K. Richer
    Haihua Gu
    Scientific Reports, 7
  • [27] Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance
    Emde, Anna
    Mahlknecht, Georg
    Maslak, Kerstin
    Ribba, Benjamin
    Sela, Michael
    Possinger, Kurt
    Yarden, Yosef
    TRANSLATIONAL ONCOLOGY, 2011, 4 (05): : 293 - 300
  • [28] Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
    Garrett, Joan T.
    Olivares, Maria Graciela
    Rinehart, Cammie
    Granja-Ingram, Nara D.
    Sanchez, Violeta
    Chakrabarty, Anindita
    Dave, Bhuvanesh
    Cook, Rebecca S.
    Pao, William
    McKinely, Eliot
    Manning, H. C.
    Chang, Jenny
    Arteaga, Carlos L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) : 5021 - 5026
  • [29] The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase
    O'Hagan, RC
    Hassell, JA
    ONCOGENE, 1998, 16 (03) : 301 - 310
  • [30] The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase
    Rónán C O'Hagan
    John A Hassell
    Oncogene, 1998, 16 : 301 - 310
12345